Animal Assisted Therapy Intervention for Hospitalized Patients in a Tertiary Care Center


About this study

The purpose of this study is to evaluate the common symptoms leading to an Animal Assisted Therapy consult, and to measure its (AAT) influence on the symptoms and feelings of hospitalized patients.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: (Patients):

  • Patients admitted to St Mary's or Methodist Hospital and subsequently referred for AAT.
  • Subjects undergoing Animal Assisted Therapy as part of their standard care.
  • Patients 18-80 years of age.
  • Patients who are able to read and answer pre- and post-intervention survey questionnaire and satisfaction survey.

Inclusion Criteria (Care Team Members):

  • Care team members of the study participants.
  • 18-80 years of age.
  • Who are able to read and answer pre- and post-intervention survey questionnaire and satisfaction survey.

Exclusion Criteria: Exclusion Criteria (Patients):

  • Patients with diagnoses of bipolar disorder, schizophrenia or dementia.
  • Unable to give consent.
  • Pregnant women (as verbalized by participant).

Exclusion Criteria (Care Team Members):

  •  Care team members of the study participants who do not want to participate.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Brent Bauer, M.D.

Closed for enrollment

More information


Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions